Back

Characterization of ATM gene expression and evaluation of Reactive Oxygen Species in Silibinin-treated SKBR3 cells

Nademi, N. S.; Motamed, N.

2026-07-09 cancer biology
10.64898/2026.07.02.736131 bioRxiv
Show abstract

BackgroundReactive Oxygen Species (ROS) are the small, unstable and highly reactive species, having DNA oxidizing ability. Oxidation of the DNAs purine and pyrimidine bases can lead to single or double strands in this macromolecule. In this situation, the ATM molecule, a serine-threonine kinase, targets several proteins for phosphorylation, which causes the cell cycle to stop and the DNA damage repair begins. It has previously been proven that natural polyphenols have the cancer inhibiting properties due to their high efficacy and low side effects. Silibinin is the main herbal and medical ingredient in Milk Thistle (Silybum marianum) is a polyphenol flavonolignan, which has been widely considered as an antioxidant and anticancer agent. The purpose of the present study was to investigate the ATM gene expression and measurement of reactive oxygen species (ROS) in SKBR3 cell line, treated with Silibinin. Materials and MethodsAt first, the SKBR3 cell line was cultured in RPMI1640 culture medium and MTT assay was carried out to evaluate the Silibinin cytotoxicity. Flow Cytometry was carried out for cell cycle analysis, apoptotic induction, and ROS detection. While, Real Time PCR was used to evaluate the ATM gene expression in the Silibinin-treated and un-treated SKBR3 cells. ResultsPresent results have shown that 150 {micro}M Silibinin had the most significant cytotoxicity and apoptotic induction influence after the treatment period of 48 h. Flow cytometry data have shown that Silibinin induced considerable amount of apoptosis and caused cell cycle arrest at G1/S phase and induced production of ROS. Real-time PCR results have revealed that Silibinin increased the ATM expression in SKBR3 cell line. ConclusionSilibinin causes increased ATM gene expression by inducing ROS production, which initiates cell cycle arrest and apoptotic induction in SKBR3 cells line.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

1
PLOS ONE
5266 papers in training set
Top 3%
35.8%
2
Molecular Biology Reports
21 papers in training set
Top 0.1%
4.2%
3
PeerJ
308 papers in training set
Top 2%
3.6%
4
Scientific Reports
3612 papers in training set
Top 28%
3.6%
5
BioMed Research International
28 papers in training set
Top 0.3%
3.4%
50% of probability mass above
6
Heliyon
152 papers in training set
Top 1%
2.9%
7
Molecules
39 papers in training set
Top 0.4%
2.5%
8
Gene Reports
14 papers in training set
Top 0.2%
2.5%
9
Frontiers in Pharmacology
111 papers in training set
Top 1%
2.0%
10
Biochemistry and Biophysics Reports
30 papers in training set
Top 0.3%
1.8%
11
Life Sciences
27 papers in training set
Top 0.4%
1.8%
12
Journal of Biomolecular Structure and Dynamics
43 papers in training set
Top 0.6%
1.8%
13
Gene
46 papers in training set
Top 0.8%
1.8%
14
Oncotarget
18 papers in training set
Top 0.1%
1.6%
15
BMC Cancer
67 papers in training set
Top 1%
1.4%
16
International Journal of Molecular Sciences
494 papers in training set
Top 10%
1.2%
17
Pharmaceuticals
34 papers in training set
Top 0.7%
1.2%
18
ACS Omega
105 papers in training set
Top 2%
1.2%
19
Frontiers in Oncology
103 papers in training set
Top 2%
1.2%
20
Bioscience Reports
27 papers in training set
Top 1%
1.1%
21
Computational Biology and Chemistry
28 papers in training set
Top 0.8%
1.0%
22
RSC Advances
22 papers in training set
Top 0.8%
0.9%
23
Biomolecules
100 papers in training set
Top 3%
0.6%
24
Biomedical Signal Processing and Control
22 papers in training set
Top 0.8%
0.6%
25
Genes
144 papers in training set
Top 4%
0.6%
26
Biochemical and Biophysical Research Communications
84 papers in training set
Top 3%
0.5%
27
Journal of Clinical Medicine
97 papers in training set
Top 6%
0.5%
28
Cells
249 papers in training set
Top 9%
0.5%
29
F1000Research
88 papers in training set
Top 5%
0.5%
30
BMC Microbiology
49 papers in training set
Top 2%
0.5%